A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Triple Negative Breast Cancer
Related studies linked through entity extraction aliases.
Neoadjuvant Angiogenesis-Targeting Bispecific Chemoimmunotherapy for TNBC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Granzyme B-PET: Predicting Immunotherapy Efficacy in TNBC
- Status
- RECRUITING
- Phase
- N/A
A Study of Trastuzumab Rezetecan in Combination With Adebrelimab Versus Investigator's Choice of Therapy in Subjects With Residual Triple Negative Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Study of the TheraBionic P1 Device in Patients With Metastatic Triple Negative Breast Cancer After Progression
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Blood and imagE-guided Optimization of Neoadjuvant Therapy in People With Early Stage Triple-negative Breast cancER - the BETTER Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase III Study of JSKN016 Versus Treatment of Physician's Choice in Patients With Triple-Negative Breast Cancer Who Have Failed Standard of Care
- Status
- RECRUITING
- Phase
- PHASE3
Gemcitabine vs Paclitaxel in Caribbean Women of African Ancestry With Metastatic Triple-Negative Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- Status
- RECRUITING
- Phase
- PHASE1
Early Detection of Metastatic Recurrence Among Patients With Stage II or III Triple Negative Breast Cancer Using Liquid Biopsy and Imaging
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Omission of Surgery for Triple-negative Breast Cancer in Complete Response After Neoadjuvant Chemo-immunotherapy
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype
- Status
- RECRUITING
- Phase
- PHASE1
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
- Status
- RECRUITING
- Phase
- PHASE2
ctDNA Positive Patients Diagnosed With cT1bN0 and cT1cN0 TNBC
- Status
- RECRUITING
- Phase
- N/A
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Personalized Cancer Vaccine (PCV) Strategy in Triple Negative Breast Cancer Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours
- Status
- RECRUITING
- Phase
- PHASE1
Neoadjuvant Serplulimab Plus Weekly Paclitaxel and Carboplatin in TNBC (Neo-SERPENT)
- Status
- RECRUITING
- Phase
- PHASE2